Novartis AG (NVS)
NYSE · American depositary receipt
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow NVS in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on NVS and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
NVS at a glance
Key statistics
$292.03B
Market capitalization
- Previous close
- $153.64
- Open
- $153.15
- Day range
- $152.95 – $154.06
- Volume
- 617.5K
- Average volume (30 sessions)
- 1.93M
- Shares outstanding
- 2.03B
- Price / earnings
- 43.2
- Earnings per share
- $3.55
- Price / book
- 4.0
- Price / sales
- 5.9
- Dividend yield
- 2.22%
- Beta (1 year, vs SPY)
- 0.32
Where the price sits in its year
52-week range
66% of the range
- Below the 52-week high
- -9.8%
- Above the 52-week low
- +26.4%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $144.94+6.0%
- 50-day average
- $148.06+3.8%
- 200-day average
- $151.23+1.6%
Between the conventional 30 and 70 bands.
+7.9%
1 week
+9.0%
1 month
+0.4%
3 months
+11.4%
Year to date
+16.9%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with NVS
NVS on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on NVS.
See the plans →
Every planScreen names like NVS
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on NVS
Put NVS on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on NVS
See whether there is an open premium alert on NVS, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
NVS headlines
- Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
GlobeNewswire Inc. · Oct 7, 2026
- Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
GlobeNewswire Inc. · Sep 18, 2026
- Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
GlobeNewswire Inc. · Sep 4, 2026
- Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials
GlobeNewswire Inc. · Sep 1, 2026
- Palmoplantar Pustulosis Market Report Now Available — Profiles AbbVie, Johnson & Johnson, Novartis, Amgen, UCB, and 4 Other Key Players, Segmented by Treatment Type and Distribution Channel
GlobeNewswire Inc. · Aug 31, 2026
SEC Form 4, most recent first
Insider filings
No insider transactions reported for NVS recently. ETFs and many foreign issuers do not file Form 4.
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
- Exchange
- NYSE
- Security
- American depositary receipt
- Employees
- 75,267
- Listed since
- Nov 7, 1996
- Website
- novartis.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.